DC Circ. Backs FDA Denial Of Rx-Only MiraLAX Generics
The U.S. Food and Drug Administration was correct to block generic-drug makers from releasing prescription versions of Bayer's MiraLAX once the branded drug switched to over-the-counter, as both versions of the...To view the full article, register now.
Already a subscriber? Click here to view full article